Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    661
  • comments
    0
  • views
    2,157

About this blog

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies offering drug repurposing services. 

§  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.

§  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

  • Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  Small Molecule

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

Key companies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

 

Entries in this blog

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030(RootsAnalysis)

https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html   Key Inclusions §  A detailed review of the overall landscape of  fragment-based drug discovery library and service providers along with the information on type of product (library and technology), type of service offered (fragment screening and fragment optimization), type of technique used (X-ray crystallography, nuclear magnetic resonance, surface plasmon resonance, and other screening t

Over 85 firms are involved in providing fragment-based drug discovery-related services(Roots)

To order this 170+ page report, which features 55+ figures and 80+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html   The USD 1.6 billion (by 2030) financial opportunity within the fragment-based drug discovery market has been analyzed across the following segments: §  Type of Screening Technique Used §  X-ray Crystallography §  Nuclear Magnetic Resonance §  Surface Plasmon Resonance §  Othe

The fragment-based drug discovery market is projected to grow <RootsAnalysis>

Roots Analysis has done a detailed study on Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 170+ page report, which features 55+ figures and 80+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html   Key Market Insights §  Over 85 firms are involved in pr

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030<Roots>

Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includ

The ‘Blood-Brain Barrier (BBB) Market, 2020-2030{RootsAnalysis}

Key Inclusions §  An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters, such as status of development (developed and under development), affiliated approach, type of compatible pharmacological molecule(s) crossing the BBB (small molecule and biologic), target receptor(s), target disease indication(s), patent availability, and licensing activity. In addition, it presents a detailed assessment

More than 110 drugs, capable of penetrating this elusive barrier{Roots}

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.   To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this link   The USD

The BBB penetrating drugs market is projected to grow at an annualized rate of ~154%:By RootsAnalysis:

Roots Analysis has done a detailed study on Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this link   Key Market Insights §  More than 110 drugs, capable of penetrating this elusive barrier

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030:By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of BBB penetration technologies and affiliated drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse ca

The ‘AR / VR based Healthcare Digital Marketing Service Providers, 2020-2030:RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html   Key Inclusions: §  A review of the current market landscape of companies offering AR / VR based digital marketing services, featuring type of technology (AR, VR and MR), AR / VR specific services (video / content generation, website development, mobile application development and game development), additional digital marketing services (consulting, content marketing, customer relationship m

Presently, more than 120 companies claim to offer AR / VR and affiliated digital marketing{RootsAnalysis}

Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers

The AR / VR based digital marketing service providers in healthcare sector market{Roots}

Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Servicev Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 180+ page report, which features 45+ figures and 70+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html   Key Market Insights §  Presently, more than 120 compani

The market opportunity for AR / VR based healthcare digital marketing service(RootsAnalysis)

Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content   Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Servicev Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.     The report features an

The opportunity for AR / VR based digital marketing service providers(Roots)

Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Servicev Providers Market, 2020-2030” report to its list of offerings.   Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given t

The “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html   Key Inclusions §  A detailed review of the overall landscape of the non-invasive cancer diagnostics market, featuring information on the developers of such products and analyses based on a number of relevant parameters, such as year of establishment, company size, geographical location, current development status of proprietary liquid biopsy test (under development, research use only, and

Nearly 300 non-invasive diagnostic tests, designed for the detection of various<Roots>

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.   To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html   The financial opportunity within the liq

The non-invasive cancer diagnostics market is projected to grow at an annualized rate of ~20%: By RootsAnalysis:

Roots Analysis has done a detailed study on Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-b

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capab

Over 230 cobots, having variable payload capacities and degrees of freedom{Roots}

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of cobots has decreased owing to growing demand for such machines across various industries, including automobiles, electronics / electrical goods, food and beverages, as well as life sciences / pharmaceuticals.

Over 230 cobots, having variable payload capacities and degrees of freedom{Roots}

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of cobots has decreased owing to growing demand for such machines across various industries, including automobiles, electronics / electrical goods, food and beverages, as well as life sciences / pharmaceuticals.

The global collaborative robots (cobots) market is projected to grow(RootsAnalysis)

Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030.” , covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 245+ page report, which features 80+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html   Key Market Insights §  Several players are currently engaged in the development and / or ma

The global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030(Roots)

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”   The report features an extensive study of the potential applications, current landscape and the likely adoption of cobots across various industrial applications, over the next decade. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the s

The “Companion Diagnostics Development Services Market, 2020-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html   Key Inclusions §  A detailed assessment of the current market landscape of companies offering companion diagnostics services, including information on the type of services offered, type of analytical technique used and regulatory certifications / accreditations, and other company-specific details (such as year of establishment, company size and geographical location). §  Tabulated pr

Over 180 companies from different regions across the globe presently<Roots>

It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house expertise. On the other hand, there are numerous contract service providers, offering vast portfolios of services for diagnostic test / assay development. Such companies are known to possess extensive technical knowledge, and experience in working with cutting-edge analytical tools and technologies, such as in situ hybridization (ISH), immunoh

The Companion Diagnostics Development Services Market is projected to grow: By RootsAnalysis:

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market, 2020-2030 covering key aspects of the industry and identifying future growth opportunities     To order this 320+ page report, which features 120+ figures and 115+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html   Key Market Insights §  Over 180 companies from different regions across the globe prese

The Companion Diagnostics Development Services Market:By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade. It features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:
×
  • Create New...